During autumn harvest, switching swine herds to freshly harvested corn frequently triggers severe diarrhea, malabsorption, and growth stalling. Fresh corn possesses elevated resistant starch, excessive moisture, and active anti-nutritional factors that disrupt digestive physiology, fueling an opportunistic proliferation of toxin-secreting Clostridium perfringens. Lytic bacteriophages offer a precision biocontrol tool to eliminate pathogenic clostridia without antibiotic resistance.
In poultry production, secondary Avian Pathogenic Escherichia coli (APEC) infections following Mycoplasma or viral challenges cause devastating mortality, airsacculitis, and fibrinous pericarditis/perihepatitis. Mycoplasma destroys tracheal mucosal ciliary defenses, allowing opportunistic pathogens to penetrate the bloodstream. Confronting antimicrobial resistance (AMR), bacteriophages offer decisive advantages through nanoscale receptor-targeted physical wall lysis, gut microbiome preservation, in situ self-amplification, and proven genomic biosafety, providing a green biocontrol paradigm.
In modern poultry production, Avian Pathogenic Escherichia coli (APEC) infections leading to 'pericarditis and perihepatitis' cause devastating mortality and severe economic loss through soaring FCR and carcass condemnations. Triggered by environmental stress and airsacculitis, APEC penetrates vascular barriers into the bloodstream, releasing massive lipopolysaccharide (LPS) endotoxins that cause extensive fibrinous exudation encapsulating vital organs. Against the rise of multi-drug resistant (MDR) and ESBL superbugs that foil conventional antibiotics, bacteriophages deliver targeted bacterial lysis, cease endotoxin leakage to promote host enzymatic pseudomembrane reabsorption, and achieve rapid visceral biodistribution via oral drinking water. Groundbreaking 2026 trials demonstrate 0% mortality and complete resolution of internal organ lesions, providing an advanced green biocontrol standard.
With the rapid intensification of modern aquaculture, antimicrobial resistance (AMR) triggered by antibiotic abuse has become an existential challenge. Marine aquaculture (high salinity, strong buffer capacity, high osmotic pressure) and freshwater aquaculture (fragile buffer systems, volatile microecology, co-infection by Aeromonas and opportunistic bacteria) present vastly distinct sediment and pathogen control dynamics. As highly targeted, natural green biocontrol agents, bacte...
In collaboration with clinical medical centers and Nanjing Agricultural University, New-Line Bio co-published breakthrough research in Frontiers in Microbiology on prophage mining in clinical MRSA strains and the discovery of novel endolysin Lys81, demonstrating potent lytic efficacy across multidrug-resistant staphylococcal biofilms.
A primary concern among livestock producers transitioning from antibiotics is whether chronic phage exposure mimics antibiotic resistance. Evolutionary biology demonstrates that bacterial phage-resistance mutations carry severe fitness costs (attenuated virulence, restored antibiotic sensitivity). Furthermore, New-Line Bio’s multi-receptor cocktail design continuously circumvents resistance mechanisms.
With broiler margins opening up, managing seasonal respiratory and systemic colibacillosis is decisive. New-Line Bio’s automated phage fine aerosol spray protocol in poultry houses directly reduces airborne and surface pathogenic E. coli loads by multiple log orders, slashing early-stage mortality and airsacculitis.
Severe enrofloxacin and florfenicol residue exceedances in commercial bullfrog farming have triggered massive market penalties. New-Line Bio’s targeted aquatic phage cocktail clears Aeromonas hydrophila and Edwardsiella in water and intestinal tracts, achieving complete antibiotic substitution without withdrawal delays.
Immature gut immunity makes neonate chicks exceptionally susceptible to perinatal colibacillosis and omphalitis. Supplying specific lytic bacteriophages in early drinking water equips chicks with rapid biological barriers that outcompete pathogens during the critical 72-hour window.
Salmonella Pullorum evades conventional antibiotics through intracellular persistence in macrophages and systemic vertical transmission. New-Line Bio’s virulent phage cocktail intercepts pathogens prior to mucosal translocation, disrupting colonization cascades and providing breeder flocks with effective negative-status maintenance.
Conventional aquatic antibiotic treatments often trigger severe immunosuppression in aquatic animals, creating vulnerability to secondary opportunistic infections. Research confirms that precision phage therapy eliminates pathogens while sparing gut microbiota, actively upregulating serum and mucosal IgM antibody titers to bolster systemic defense.
In pet clinics, the pursuit of rapid clinical responses has led to growing reliance on carbapenems like imipenem—the last line of human medical defense. This abuse accelerates carbapenem-resistant Enterobacteriaceae (CRE) emergence. New-Line Bio highlights precision lytic bacteriophages as sustainable, residue-free alternatives that protect both animal welfare and public health.